It does not work without YOUR input

 

Before a new medicinal product is introduced to the market, safety, efficacy and tolerability have to be tested. YOU have the experience with your product and we have the experience how to bring YOUR product to YOUR planned market.  

LaNova Consulting one step ahead
LaNova Consulting                             one step ahead

INNOVA HC in Saudi Arabia

Expertise builds Bridges....

 

....within the family of LaNova Consulting (Europe) and INNOVA HC (Saudi Arabia), we offer our  services to the Pharma Market (Pharmaceutical, Generic, Biotech and Medical Device Companies) as well as to Clinical Research Organisations and academic institutions in the MENA Region (GCC Countries).

 

The following summary is an outline of the unique capabilities that allow LaNova Consulting together with INNOVA HC to differentiate in Pharamcovigilance, Clinical Trials, Health Economics and Market Access in the MENA Region GCC Countries).....

 

....in the GCC Region:

 

  •  Clinical Trial Competencies (Late Phase)
  •  Non Interventional Studies (NIS)
  •  Patient Reported Outcomes (PROs)
  •  Ethics and Regulatory Submissions
  •  Market Access - Dossier Submissions
  •  Operational Competencies
  •  Pharmacovigilance Services
  •  Investigator Service and Support
  •  GxP Training Courses

 

Please refer to  our Company Profile Presentation for LaNova Consulting & INNOVA HC

ePaper
Teilen:
Druckversion Druckversion | Sitemap
© LaNova.eu